Trial Profile
A pharmacokinetic study of the interaction between celecoxib and anticonvulsant drugs [phenytoin, carbamazepine, phenobarbital, primidone, gabapentin, lamotrigine, valproic acid, levetiracetam, tiagabine, topiramate, zonisamide, felbamate, oxcarbazepine] in patients with newly diagnosed glioblastoma multiforme undergoing radiation therapy.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Carbamazepine; Felbamate; Gabapentin; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenobarbital; Phenytoin; Primidone; Tiagabine; Topiramate; Valproic acid; Zonisamide
- Indications Glioblastoma
- Focus Pharmacokinetics
- 02 May 2012 Actual patient number is 35 according to ClinicalTrials.gov.
- 18 Apr 2008 New trial record.